EOLS
Evolus, Inc.
OpenVolumeMkt capP/EEPSDiv yield
Day – 52-wk –
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Evolus, Inc.
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorporated in 2012 and is headquartered in Newport Beach, California.
Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorporated in 2012 and is headquartered in Newport Beach, California.
Last report2 of 8 at or beyond impliedshaded = implied▲▼ = realized× = |realized| ÷ implied
No other changes.
No other changes.
Annual filing, covered
10-K parsed · Mar 3 '26
Supply-chain ties, covered
Disclosed · both directions
Fund holders, covered
N-PORT holdings
13F holdings, covered
13F quarter · Jun 30 '26
Management, not covered
Not covered · DEF 14A, 8-K 5.02
Company IR feed, not covered
News via newswires & EDGAR
Products, patents, hiring, not covered
Not covered
Annual filing, covered
10-K parsed · Mar 3 '26
Supply-chain ties, covered
Disclosed · both directions
Fund holders, covered
N-PORT holdings
13F holdings, covered
13F quarter · Jun 30 '26
Management, not covered
Not covered · DEF 14A, 8-K 5.02
Company IR feed, not covered
News via newswires & EDGAR
Products, patents, hiring, not covered
Not covered
No thesis.
Evolus, Inc.
7.47
+0.10 · +1.33%
post 7.55 +1.10%
Same SIC code · 6
Same SEC industry code: ELI Lilly & Co, Johnson & Johnson, AbbVie Inc. and 3 more; of Evolus, Inc.'s 6 closest co-movers, none share that code.
Same SIC code · 6
Same SEC industry code: ELI Lilly & Co, Johnson & Johnson, AbbVie Inc. and 3 more; of Evolus, Inc.'s 6 closest co-movers, none share that code.
Largest filed tie
—
News
—
—
| Manager | Value | % base | |
|---|---|---|---|
| Nantahala | $38.9M | 11.36% | −12.15% |
| BlackRockindex-like | $33.6M | 9.81% | +12.83% |
| Braidwell | $21.9M | 6.40% | +1.61% |
| Frazier Life Sciences | $18.3M | 5.33% | 0.00% |
| Perceptive | $17.1M | 4.98% | +91.11% |
| Manager | Value | % base | |
|---|---|---|---|
| Nantahala | $38.9M | 11.36% | −12.15% |
| BlackRockindex-like | $33.6M | 9.81% | +12.83% |
| Braidwell | $21.9M | 6.40% | +1.61% |
| Frazier Life Sciences | $18.3M | 5.33% | 0.00% |
| Perceptive | $17.1M | 4.98% | +91.11% |
Expected move
Inputsspot 7.47exp Jan 15ATM strike 7.5ATM straddle 1.78IV 68%